Apple has recorded a remarkable 23% jump in China smartphone sales during the first nine weeks of 2026, outperforming a broader market that contracted by 4% over the same period. The surge highlights Apple's strengthening position in one of the world's most competitive mobile markets, even as overall consumer demand remains sluggish despite government subsidy programs introduced at the start of the year.
The Cupertino-based tech giant's growth was fueled by attractive e-commerce discounts and its qualification for state subsidies on the base iPhone 17 model, making it more accessible to cost-conscious Chinese consumers. Research firm Counterpoint, which released the data, attributed Apple's resilience largely to its well-managed supply chain, which gives it a significant cost advantage over Android competitors currently grappling with soaring memory chip prices.
Unlike rival manufacturers such as OPPO and vivo — both of which have announced price hikes on select existing models this month — Apple is expected to hold its pricing steady. Counterpoint analysts suggest the company will absorb some of the margin pressure rather than pass costs on to buyers, a calculated move that could help Apple capture additional market share as competitors raise their prices. These Android makers are also using the price adjustments strategically, testing consumer tolerance ahead of upcoming product launches to guide future pricing decisions.
Huawei, however, presents a different competitive dynamic. Its heavy reliance on domestic chip suppliers, which typically price below international alternatives, provides a natural buffer against rising memory costs. This advantage could allow Huawei to aggressively pursue the low-to-mid-range segment of the market.
Looking ahead, Counterpoint forecasts continued market pressure through May, with potential relief arriving in early June during China's major mid-year "618" shopping festival. The ongoing memory cost crunch is expected to challenge all smartphone makers throughout 2026, forcing difficult decisions around pricing, margins, and shipment targets.


Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
SoftBank Shares Slide Despite Record Q4 Profit Fueled by OpenAI Investment
OpenAI Wins Elon Musk Lawsuit as Jury Rejects Claims Over AI Mission
Standard Chartered Targets Higher Profitability With Major Workforce Cuts
Samsung Faces Major Strike Threat as Union Restarts Pay Talks
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower
Warren Buffett and Stephen Curry Charity Dinner Auction Raises $27 Million for Nonprofits
Arteris Stock Surges After Strong Q1 Earnings Beat and Higher 2026 Outlook
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes
Anthropic Nears $30 Billion Funding Round at $900 Billion Valuation
Alibaba Stock Surges After Strong Q4 Earnings Boosted by AI and Cloud Growth
Elliott Targets Bio-Rad as Shares Continue to Struggle
Honda Shares Jump as Automaker Forecasts Profit Recovery Despite Historic Loss 



